We are monitoring the impact of COVID-19 on North America Pen Needles Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 150
Share on
Share on

North America Pen Needles Market Research Report – Segmented By Therapy, Type, Needle Length, Mode Of Purchase & Country (The United States, Canada, Mexico and Rest of North America) - Market Analysis, Size, Geographic Countries Analysis, Competitive Strategies Analysis (2021 to 2026)

Pulished: April, 2021
ID: 150
Pages: 135

North America Pen Needles Market Size (2021 to 2026)

The Pen needles market in North America is expected to reach USD 1.06 billion by 2026 from USD 0.64 billion in 2021, growing at a CAGR of 10.60% from 2021 to 2026.

The growing occurrences of chronic diseases and illness, mainly diabetes, cancers, cardiovascular issues, raise demand for the pen needles market. The ever increasing geriatric population, spread rate of infections, increase in the number of people who have diabetes, type 1, and type 2 lead to market growth. In recent times besides syringes and minimally invasive devices, vials; pen needles are more preferred, which drives demand for the availability and usage of pen needles. Growing awareness in people about self-checking or testing and self-medication, administering the drug in insulin therapy by patients with diabetes type 1 and type 2 increases market size.

Technological advancements, more R & D activities, innovative ideas for designing more medical devices with high patient compliance, focus shifts on patients' pain management increase market size. Other factors, such as the adaption of minimally invasive surgeries and the rise in public awareness for a healthy lifestyle, government’s healthcare benefits and schemes, and easy commute to hospitals, clinics, and health centers, increase market size. The rise in global investors, rise in economy, and spending on this market increased government and public funding to improve the pen needles market.

On the other hand, there are few market restraints faced by this market, which will hinder the growth of the pen needles market in this region. Factors such as safety concerns, pain management inpatient population, focus shift on patient compliance, and other potential reasons effects market size. The rise in preference of other alternative techniques restricts the pen needles market to grow. Needlestick injuries, reuse of pen needles are the main concerns for this market to grow.

COVID impact:

COVID 19 cases all around the world are rising. The shortage of minimal medical devices and other needed medical essential supplies are seen during recent times. In order to prevent widespread infections, there is more demand for these medical devices and supplies. An increase in the number of cases, the spread of disease, and the death toll is observed in recent times. More critical care is required for a patient population in severe condition and is on ventilators, for which more medical staff and professionals are also needed to assist. Social distancing is the only way to eradicate the spread of coronavirus.

This research report on the North America Pen Needles Market has been segmented and sub-segmented into the following categories:

  • By Therapy: Insulin Therapy, GLP-1 Therapy, and Growth Hormone Therapy
  • By Type: Standard Needle and Safety Needle
  • By Needle Length: 4mm, 6mm, 8mm, 10mm, and 12mm
  • By Mode of Purchase: Retail and Non-Retail
  • By Country: The United States, Canada, Mexico, and Rest of North America

Regional Analysis: 

Based on geographical areas, The U.S. is estimated to account for a larger share of the North America pen needles market in 2019. In contrast, Canada is estimated to grow at a higher CAGR during the forecast period.

North America is expecting steady growth in the pen needles market during the forecast period. Factors such as rise in the geriatric population, favorable healthcare economy, spending, reimbursement plans, rise in chronic diseases, rise in demand for standards and safety, and advancement in inpatient population safety concerns increase market size.

The United States stands first for well-developed technology and research activities for the medical devices market. Canada, with its highest recorded patients suffering from various illnesses, increases market size. The adaption of pen needles by the diabetic population is a major driving factor for this market. According to reports by the CDC, 100 million people are suffering from diabetes and pre-diabetes. Hence the need for pen needles in the process of treatment and procedures increases the market size.

Companies like Becton Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), UltiMed, Inc. (U.S.), Allison Medical, Inc. (U.S.), Owen Mumford, Ltd. (U.K.), B. Braun Melsungen (Germany), Artsana S.p.a. (Italy), HTL-STREFA S.A. (Poland), Terumo Corporation (Japan) are leading the North American Pen Needles Market.

  1. Introduction

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

  1. Research Methodology

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

  1. Overview

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

  1. Market Segmentation

                5.1          Therapy                                                              

                                5.1.1 Introduction                                                           

                                5.1.2 Insulin Therapy                                                     

                                5.1.3 GLP-1 Therapy                                                       

                                5.1.4 Growth Hormone Therapy                Growth Hormone Therapy                                         

                5.2          Type                                                     

                                5.2.1 Introduction                                                           

                                5.2.2 Standard Needle                                                  

                                5.2.3 Safety Needle                                                       

                5.3          Needle Length                                                 

                                5.3.1 Introduction                                                           

                                5.3.2 4mm                                                          

                                5.3.3 6mm                                                          

                                5.3.4 8mm                                                          

                                5.3.5 10mm                                                        

                                5.3.6 12mm                                                        

                5.4          Mode of Purchase                                                          

                                5.4.1 Introduction                                                           

                                5.4.2 Retail                                                         

                                5.4.3 Non-Retail                                                               

  1. Geographical Analysis

                                6.1 Introduction                                                               

                                6.2 United States                                                            

                                6.3 Canada                                                         

  1. Strategic Analysis

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

  1. Market Leaders' Analysis

                8.1          Becton, Dickinson and Company (U.S.)                                                 

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2          Novo Nordisk A/S (Denmark)                                                    

                8.3          Ypsomed Holding AG (Switzerland)                                                        

                8.4          UltiMed, Inc. (U.S.)                                                        

                8.5          Allison Medical, Inc. (U.S.)                                                          

                8.6          Owen Mumford, Ltd. (U.K.)                                                       

                8.7          B. Braun Melsungen (Germany)                                                               

                8.8          Artsana S.p.a. (Italy)                                                      

                8.9          HTL-STREFA S.A. (Poland)                                                            

                8.10        Terumo Corporation (Japan)                                                      

  1. Competitive Landscape

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 


  1. List of Tables
  2. List of Figures
  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market


  1. North America Pen Needles Market, By Region, From 2021 to 2026 (USD Million)
  2. North America Pen Needles Market, By Type, From 2021 to 2026 (USD Million)   
  3. North America Standard Needles Market, By Region, From 2021 to 2026 (USD Million)   
  4. North America Safety Needles Market, By Region, From 2021 to 2026 (USD Million)
  5. North America Pen Needles Market, By Therapy, From 2021 to 2026 (USD Million)          
  6. North America Insulin Therapy Market, By Region, From 2021 to 2026 (USD Million)           
  7. North America GLP-1 Therapy Market, By Region, From 2021 to 2026 (USD Million)         
  8. North America Growth Hormone Therapy Market, By Region, From 2021 to 2026 (USD Million)   
  9. North America Pen Needles Market, By Needle Length, From 2021 to 2026 (USD Million)       
  10. North America 4mm Pen Needle Length Market, By Region, From 2021 to 2026 (USD Million)           
  11. North America 6mm Pen Needle Length Market, By Region, From 2021 to 2026 (USD Million)           
  12. North America 8mm Pen Needle Length Market, By Region, From 2021 to 2026 (USD Million)  
  13. North America 10mm Pen Needle Length Market, By Region, From 2021 to 2026 (USD Million)
  14. North America 12mm Pen Needle Length Market, By Region, From 2021 to 2026 (USD Million)         
  15. North America Pen Needles Market, By Mode of Purchase, From 2021 to 2026 (USD Million)
  16. North America Retail Market, By Region, From 2021 to 2026 (USD Million)                            
  17. North America Non-Retail Market, By Region, From 2021 to 2026 (USD Million)   
  18. United States Pen Needles Market, By Type, From 2021 to 2026 (USD Million)     
  19. United States Pen Needles Market, By Therapy, From 2021 to 2026 (USD Million)
  20. United States Pen Needles Market, By Needle Length, From 2021 to 2026 (USD Million)
  21. United States Pen Needles Market, By Mode of Purchase, From 2021 to 2026 (USD Million)
  22. Canada Pen Needles Market, By Type, From 2021 to 2026 (USD Million)                        
  23. Canada Pen Needles Market, By Therapy, From 2021 to 2026 (USD Million)                          
  24. Canada Pen Needles Market, By Needle Length, From 2021 to 2026 (USD Million)           
  25. Canada Pen Needles Market, By Mode of Purchase, From 2021 to 2026 (USD Million)                     

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample